KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.553 $1.13 Friday, 26th Apr 2024 BLRX stock ended at $0.612. This is 6.31% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 12.45% from a day low at $0.553 to a day high of $0.622.
90 days $0.553 $1.44
52 weeks $0.553 $2.53

Historical BioLineRx Ltd. prices

Date Open High Low Close Volume
Mar 23, 2023 $0.789 $0.789 $0.760 $0.770 350 156
Mar 22, 2023 $0.740 $0.799 $0.700 $0.760 864 545
Mar 21, 2023 $0.602 $0.760 $0.602 $0.737 1 213 293
Mar 20, 2023 $0.606 $0.635 $0.567 $0.630 417 477
Mar 17, 2023 $0.600 $0.613 $0.580 $0.612 155 374
Mar 16, 2023 $0.605 $0.610 $0.592 $0.609 93 784
Mar 15, 2023 $0.596 $0.615 $0.580 $0.609 352 035
Mar 14, 2023 $0.580 $0.603 $0.580 $0.600 129 103
Mar 13, 2023 $0.573 $0.594 $0.565 $0.588 170 102
Mar 10, 2023 $0.570 $0.582 $0.550 $0.569 388 041
Mar 09, 2023 $0.580 $0.600 $0.577 $0.577 158 861
Mar 08, 2023 $0.582 $0.600 $0.573 $0.589 115 958
Mar 07, 2023 $0.590 $0.600 $0.570 $0.586 82 569
Mar 06, 2023 $0.600 $0.620 $0.580 $0.592 277 846
Mar 03, 2023 $0.583 $0.600 $0.560 $0.591 178 786
Mar 02, 2023 $0.576 $0.600 $0.570 $0.590 179 420
Mar 01, 2023 $0.590 $0.620 $0.570 $0.590 209 385
Feb 28, 2023 $0.550 $0.600 $0.550 $0.595 397 094
Feb 27, 2023 $0.571 $0.581 $0.550 $0.581 469 291
Feb 24, 2023 $0.570 $0.580 $0.550 $0.563 305 073
Feb 23, 2023 $0.590 $0.590 $0.560 $0.580 308 631
Feb 22, 2023 $0.585 $0.599 $0.582 $0.590 179 818
Feb 21, 2023 $0.596 $0.610 $0.590 $0.600 112 120
Feb 17, 2023 $0.600 $0.620 $0.595 $0.610 55 750
Feb 16, 2023 $0.610 $0.620 $0.580 $0.609 143 622
Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT